1.
Sleijfer S, Rizzo E, Litière S, Mathijssen RHJ, Robert Judson I, Gelderblom H, et al. Predictors for doxorubicin-induced hematological toxicity and its association with outcome in advanced soft tissue sarcoma patients; a retrospective analysis of the EORTC-soft tissue and bone sarcoma group database. AO [Internet]. 2018 Aug. 3 [cited 2024 Nov. 24];57(8):1117-26. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/24870